Cadrenal Therapeutics (CVKD) Return on Assets (2023 - 2026)
Cadrenal Therapeutics (CVKD) posted Return on Assets of 0.0% for Q2 2025, up 30.92% sequentially from 0.01% in Q1 2025, and up 1.0% YoY from 0.0% in Q2 2024.
Cadrenal Therapeutics (CVKD) Return on Assets (2023 - 2026) Analysis & Trends
Cadrenal Therapeutics has reported Return on Assets for 3 years, with the latest figure at 0.0% in Q2 2025.
- Quarterly Return on Assets rose 1.0% year-over-year to 0.0% in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 0.0% (up 1.0% YoY) and the FY2023 annual result came in at 0.02%, changed N/A from the prior year.
- Return on Assets climbed to 0.0% in Q2 2025 per CVKD's latest filing, from 0.01% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q2 2025 and troughed at 0.03% in Q1 2023.
- A 3-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Assets.
- The widest YoY moves for Return on Assets: up 2 bps in 2024, down 0 bps in 2024.
- Over 3 years, Return on Assets stood at 0.01% in 2023, then increased by 18 bps to 0.01% in 2024, then jumped by 57 bps to 0.0% in 2025.
- According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.01%, and 0.01% for Q2 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 0.00% |
| 10 | Cadrenal Therapeutics | 4.66 Mn | 2.26 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.03% |